Eman Mabrouk Mahmoud Ghonaim

@pha.tanta.edu.eg

Clinical Clinical Pharmacy Department, Faculty of Pharmacy, Tanta University
Faculty of Pharmacy, Tanta University

Eman Mabrouk Mahmoud Ghonaim


               Download Compact PDF  
https://researchid.co/emanghonaim

RESEARCH, TEACHING, or OTHER INTERESTS

Pharmacy, Endocrinology, Diabetes and Metabolism, Oncology, Pharmacology, Toxicology and Pharmaceutics
3

Scopus Publications

32

Scholar Citations

2

Scholar h-index

2

Scholar i10-index

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

  • Repurposing nitazoxanide in type 2 diabetes mellitus: a randomized controlled trial
    EM Ghonaim, OM Ibrahim, SK Hegazy, WF Farrag, HR Badr
    Endocrine 90 (2), 596-604 , 2025
    2025
    Citations: 1
  • Potential impact of serpin peptidase inhibitor clade (A) member 4 SERPINA4 (rs2093266) and SERPINA5 (rs1955656) genetic variants on COVID-19 induced acute kidney injury
    SM El-Hefnawy, ZA Kasemy, HA Eid, I Elmadbouh, RG Mostafa, TA Omar, ...
    Human Gene 32, 101023 , 2022
    2022
    Citations: 11
  • Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial
    E Ghonaim, S El-Haggar, S Gohar
    Medical Oncology 38 (9), 108 , 2021
    2021
    Citations: 20

MOST CITED SCHOLAR PUBLICATIONS

  • Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial
    E Ghonaim, S El-Haggar, S Gohar
    Medical Oncology 38 (9), 108 , 2021
    2021
    Citations: 20
  • Potential impact of serpin peptidase inhibitor clade (A) member 4 SERPINA4 (rs2093266) and SERPINA5 (rs1955656) genetic variants on COVID-19 induced acute kidney injury
    SM El-Hefnawy, ZA Kasemy, HA Eid, I Elmadbouh, RG Mostafa, TA Omar, ...
    Human Gene 32, 101023 , 2022
    2022
    Citations: 11
  • Repurposing nitazoxanide in type 2 diabetes mellitus: a randomized controlled trial
    EM Ghonaim, OM Ibrahim, SK Hegazy, WF Farrag, HR Badr
    Endocrine 90 (2), 596-604 , 2025
    2025
    Citations: 1